Veritas, Luthra, Herbert, Latham lead on Claris sale of generic injectables biz to Baxter for $625 million

Published on
1 min read

Claris Lifesciences Ltd will sell its global generic injectables business to US-based Baxter International Inc. for $625 million (Rs. 4,238 crore).

Loading content, please wait...
Bar and Bench - Indian Legal news
www.barandbench.com